Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer To Discontinue Mylotarg In US
Pfizer received approval for the single agent Mylotarg, in the US, under FDA’s accelerated approval regulations based on overall response rate in three non-comparative studies and required submission
Pfizer received approval for the single agent Mylotarg, in the US, under FDA’s accelerated approval regulations based on overall response rate in three non-comparative studies and required submission
Takeda Pharma said that the once-daily prescription medication, available in two commonly used dosages of pioglitazone and metformin XR – 15 mg/1000 mg and 30 mg/1000 mg tablets,
Hematide/peginesatide is Affymax’s investigational drug for the treatment of anemia in chronic renal failure patients. Affymax and Takeda said that the payments were triggered by the achievement of
Under the terms of the agreement, BD is expected to market a number of defined LNA-enhanced products to run on the new BD Max System, BD’s platform for
Ceapro said that studies on its core ingredients including avenanthramides, beta glucan, and peptides are expected to be completed over the next year, as per the terms of
The QL Care Analyzer will be tested utilising CardioGenics’ Troponin-I test, the first in a series of four cardiovascular tests to be offered for use with the QL
Nature Made said that the GreatMind features a patent-pending combination of key ingredients that include vitamin B12, folate, amino acids and other key antioxidants. Thomas Crook, clinical psychologist,
IntelGenx said that the two main issues which need to be addressed in order to obtain approval are the qualification of a commercial manufacturing site and the food
As part of the commercialisation agreement, Diamyd holds the right to commercialise the product in the Nordic states. GAD65 is currently being assessed in Phase 3 clinical studies
Under the terms of the agreement, Saladax Biomedical and Bristol-Myers Squibb will collaborate globally on development and regulatory approvals. Saladax received exclusive global rights to commercialize the assays